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Recent studies have shown that small for gestational age (SGA) term infants undergo catch-up growth during infancy but there is limited 
studies on early growth outcomes of extreme premature SGA infants. The aim of this study was to compare factors associated during 
birth in extremely premature infants less than 28 weeks’ gestation who were born SGA (<10th percentile for gestational age) with those 
who were born appropriate-for-gestational age (AGA) (10th-89th percentile) and to determine whether there was catch-up growth at term 
equivalence. One hundred fifty-three extreme premature infants (89 males) born below 28 weeks’ gestation were prospectively recruited. 
All infants had auxological measurements undertaken and prospective data on pregnancy, maternal factors, perinatal and postnatal data 
obtained. SGA infants at birth had significantly higher Clinical Risk Index for Babies scores and mortality, lower birth weight, smaller 
head circumference, smaller mid arm circumference and shorter leg length at time of birth compared with AGA infants. However, at term 
equivalence, weight and leg length of were not significant between AGA and SGA infants born at extreme prematurity. Our study shows 
that extreme premature SGA infants have appropriate catch-up growth by the time they reach term equivalence suggesting that postnatal 
nutrition and care are important determinants of catch-up growth in SGA infants. 
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Introduction
Small for gestational age (SGA) is a term most commonly 
used to indicate infants born with a weight below the 10th 
percentile for their gestational age. Infants born SGA are at 
increased risk of perinatal morbidity, persistent short stature 
and metabolic alterations in later life (1). Infants born SGA 
with low birth length who do not achieve catch-up growth by 
the age of two years have a 7-fold higher relative risk of short 
stature than children born at normal size (2) and this risk is 
further increased by extreme prematurity (3). While the vast 
majority of SGA infants do show catch-up growth by 2 years 
of age, one in 10 does not (4,5). SGA infants who fail to catch-
up and do not reach their target height range, remain short 
throughout childhood (6,7) and approximately 10% of SGA 
children will continue to further fall below the 3rd percentile 
of height into adulthood (8,9). Intrauterine and neonatal 
growth failure of very low birth weight SGA and premature 
infants may also have long-term implications for adult health 
with risk of future adverse metabolic outcomes (8,10,11).
Abstract
What is already known on this topic?
What this study adds?
Small for gestational age (SGA) infants are at risk of impaired postnatal growth. Majority of SGA infants born at term will have catch-up 
growth by 2 years of age but there are limited studies on extreme premature SGA infants.
Extremely premature small for gestational age infants born less than 28 week’s gestation have appropriate catch-up growth by the time 
they reach term equivalence suggesting that postnatal nutrition and care are important determinants of catch-up growth in these infants.
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Accordingly, the aim of this study was compare factors 
associated during birth in extremely premature infants who 
were born SGA (<10th percentile for gestational age) with 
those who were born appropriate-for-gestational age (AGA) 
(10th-89th percentile) and to determine whether there was 
catch-up growth at term equivalence, defined in our study at 
36 weeks corrected gestational age (CGA).
Methods
In our study 153 extreme premature infants (89 males) born 
less than 28 weeks’ gestation were prospectively recruited 
from the TIPIT study and the infants were randomised 
according to trial protocol (12,13). The following were 
excluded: infants born to mothers with known thyroid disease 
or on anti-thyroid medications or amiodarone, and infants 
with major congenital or chromosomal abnormalities. This 
study is part of a post-hoc analysis to look at comparisons 
between babies born SGA versus AGA carried out at 
the Neonatal Intensive Care Unit of Liverpool Women’s 
Hospital, UK. All infants had auxological measurements 
undertaken and prospective data on pregnancy, maternal 
factors, perinatal and postnatal data obtained. Ultrasound 
assessment of the thyroid gland at 36 weeks’ CGA were 
also undertaken. Auxological measurements and data of 
SGA infants were compared with AGA infants to compare 
outcome measures at term equivalence. 
Auxology Measurements
a) Mini-knemometry
The mini knemometer was used to measure the length of 
the lower leg of the infants and to determine short term 
growth in SGA and AGA premature babies. This device has 
been validated as an accurate device for the detection of 
small growth spurts that in neonates occur within days 
(14). The mini knemometer measures the distance from 
the bottom of the heel to the top of the knee in neonates 
with the knee flexed at an approx. 90 degrees angle (Figure 
1). In order to avoid measurement bias and to develop a 
standardised method for measuring the infants leg length 
using this device, a 4-week learning period was required to 
provide reliable results. Lower leg length measurements of 
6 preterm infants were taken using the mini knemometer 
followed by repeated measurements within a day period 
for each infant. The acquired mean technical error (mean 
standard deviation of 5 sequential readings) in all 6 studied 
infants was 0.15 mm (Table 1). 
b) Mid arm circumference (MAC)
The MAC for each infant was measured using a normal non-
stretch measuring tape and measurements were rounded 
to the nearest 0.1 cm. The measuring point called the 
mid-point of the upper arm was located in the mid upper 
arm half way between the tip of the shoulder blade and 
tip of the elbow. All infants were undressed during these 
measurements.
c) Head circumference
The occipitofrontal circumference for each infant was 
measured using a normal non-stretch measuring tape and 
measurements were rounded to the nearest 0.1 cm.
Statistical Analyses
Distributions of continuous outcomes were checked. P 
values were calculated using a t-test or Mann-Whitney U 
test as appropriate. Comparisons of SGA and AGA infants 
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Figure 1. Knemometry measurement
Table 1. Reliability of mini-knemometry
1st 2nd 3rd 4th 5th SD
Case 1 45.62 45.67 45.10 45.29 45.6 0.23
Case 2 50.12 50.12 50.14 50.23 50.16 0.04
Case 3 53.45 53.44 53.45 53.41 53.44 0.14
Case 4 39.89 39.88 39.90 39.73 39.56 0.16
Case 5 51.11 51.1 51.12 51.11 51.13 0.13
Case 6 42.56 42.56 42.55 42.59 42.61 0.14
Mean SD 0.15
SD: standard deviation
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were made using univariate analyses. Statistical Package 
for the Social Sciences 21.0 was used in the data analysis. 
The study was approved by North West Research Ethics 
Committee (reference number 07/MRE08/37).
Consent
The study was approved by North West Research Ethics 
Committee (reference number: 07/MRE08/37) and by the 
Medicines for Human Regulatory Agency. The parents of 
each potentially eligible baby were informed of the study’s 
objectives and overall requirements after birth when the 
baby had achieved respiratory and haemodynamic stability. 
The Investigator explained the study fully to the patient’s 
parent(s)/guardian(s) using the patient information leaflet. 
The parent/guardian was then given at least 12 hours to 
consider the study. If a parent/guardian was willing for the 
patient to participate in the study written informed consent 
was obtained. 
Results
One hundred fifty-three infants were recruited to the study. 
The median gestational age at birth was 26.2±1.0 and mean 
birth weight was 893.8±178.1 grams. This study found that 
SGA infants at birth had significantly higher Clinical Risk 
Index for Babies scores and mortality, lower birth weight, 
smaller head circumference, smaller MAC and shorter leg 
length at time of birth compared with AGA infants. However, 
at term equivalence 36 weeks’ gestation, weight and leg 
length of SGA and AGA infants were not significant (Table 2).
Discussion 
SGA is a sign of growth failure due to maternal factors such 
as poor nutrition, chronic disease and infections (5,15), as 
well as potential environmental toxins (e.g. smoking and 
alcohol consumption) (16) and paternal factors including 
diabetes may also contribute to being born SGA (17). The 
aetiology of most SGA births remains unknown; however, 
several factors involving the foetus and placenta have been 
evaluated (15,18). Among these causes, lack of nutritional 
supply to the foetus is believed to be the primary cause of 
reduced foetal growth (19). In a Swedish population-based 
study, highest rates of mortality were observed in extremely 
premature SGA infants (15). This was in concordance with 
the results shown in our study.
General postnatal growth pattern can be divided into three 
phases: infancy, childhood, and puberty and failure of 
growth in any of these phases can reduce growth potential 
and eventually cause adult short stature (19). Studies 
have shown that SGA born neonates may experience a 
compensatory growth spurt or catch-up growth in infancy 
and childhood, however the timing of this growth spurt is 
not well described (20). Catch-up growth of infants born SGA 
mainly occurs from 6 months to 2 years and approximately 
85% of SGA children will have catch-up by two years of age 
(21), however, babies born prematurely who are SGA may 
take around four years to achieve catch-up growth (22). The 
majority of infants born SGA show catch-up growth during 
the first few months of life followed by a normal pattern 
of development (19,23). In our study, SGA infants showed 
appropriate catch-up growth by the time they reached 36 
weeks’ CGA suggesting that early postnatal nutrition and 
care were important determinants of catch-up growth in 
SGA infants. 
The thyroid hormones are essential for normal growth 
and development of the foetus and deficiency of thyroid 
hormones perinatally can impairs growth of the infant and 
compromises its adaptation to extrauterine life (24). Our 
results have not found any significant difference in either 
the maternal or infant thyroid status.
It is generally recognised that children born SGA have 
a significantly higher risk of short stature in adulthood 
than children born AGA at normal size, with a possible 
explanation that the programming of the endocrine axes 
occurs during critical phases of foetal development affected 
by intrauterine growth retardation (6). Accurate gestational 
dating and measurements of birth weight and length are 
important in identifying SGA infants. We recommend 
that comprehensive pregnancy, maternal, perinatal, and 
immediate postnatal data be obtained to help confirm 
diagnosis although often the cause of SGA remains unclear.
Limitations of the Study
Limitations of this study is the small sample size of this 
cohort of extremely premature infants born less than 28 
weeks’ gestation and the lack of data on maternal size 
or maternal glycaemic indices which could be potential 
confounding factors. Due to their extremes of viability, we 
were unable to obtain blood sampling for growth hormone 
factors and body size measurement of these infants were 
not feasible. The authors believe that the mini knemometer 
is a practical and novel method used to measure the length 
of the lower leg of the infants and to determine short term 
growth these extremely premature babies. The authors also 
acknowledge that many of extremely premature infants is 
unlikely to have appropriate catch-up growth by the time 
they reach term equivalence and factors associated with 
growth will require further research in a larger population 
group, which would be best performed as a multi-centered 
study.
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Conclusions
The mechanism of catch-up growth in premature SGA 
infants remains unclear (11). Our study shows that extremely 
premature SGA infants have appropriate catch-up growth 
by the time they reach term equivalence suggesting that 
postnatal nutrition and care are important determinants 
of catch-up growth in SGA infants. We recommend that 
early surveillance in a growth clinic for those without catch-
up is advisable and neurodevelopment evaluation and 
interventions are warranted in at-risk children who fail to 
catch-up.
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Table 2. Comparative variables of small for gestational age and appropriate-for-gestational age infants 
AGA (N=97) SGA (N=56)
Difference (95%CI)
AGA-SGA
p value
Gestation (weeks) 25.86 (1.01) 25.80 (1.78) 0.06 (-0.38, 0.51) 0.78
Birth weight (kg) 0.81 (0.17) 0.70 (0.21) 0.09 (0.02, 0.15) 0.01
Gender (male) 55 (57%) 34 (60%) -0.04 (-0.19, 0.12) 0.61β
CRIB score 5.05 (3.56) 6.41 (4.12) -1.35 (-2.61, -0.11) 0.03
Infant baseline FT4 (pmol/L) 10.86 (5.1) 12.32 (5.1) -1.45 (-4.12, 1.21) 0.28
Maternal age (years) 26.03 (7.0) 28.62 (6.90) -0.99 (-3.51, 1.52) 0.43
Maternal history of smoking during pregnancy 20 (21.0%) 16 (29.0%) -0.08 (-0.23, 0.058) 0.24β
Maternal history of alcohol during pregnancy 7 (7.2%) 3 (5.4%) 0.02 (-0.08, 0.098) 0.65β
Maternal FT4 (pmol/L) 16.57 (2.63) 15.52 (3.0) 1.04 (-0.66, 2.16) 0.06
Premature rupture of membrane 34 (35.1%) 20 (35.7%) -0.01 (0.16, 0.15) 0.97β
Evidence of maternal pyrexia >38 °C in the week before 
birth or raised maternal CRP in the week before birth 31 (32.0%) 9 (16.1%) 0.16 (0.02, 0.29) 0.03
β
Caesarian section delivery 63 (64.97%) 38 (67.8%) -0.03 (-0.18, 0.13) 0.60β
Antenatal steroids given 94 (96.9%) 51 (91.1%) 0.12β
Head circumference at screening (cm) 23.81 (1.68) 22.95 (1.90) 0.85 (0.22, 1.49) 0.001
Head circumference at 36 weeks (cm) 30.77 (1.960) 29.9 (2.14) 0.86 (0.06, 1.66) 0.51
Leg length at screening (mm) 40.19 (6.10) 39.70 (8.01) 2.95 (0.37, 5.53) 0.03
Leg length at 36 weeks (mm) 63.54 (7.3) 62.80 (10.0) 0.74 (-2.69, 4.16) 0.67
Mid arm circumference at screening (mm) 5.26 (0.55) 5.04 (0.60) 0.22 (0.008, 0.43) 0.04
Mid arm circumference at 36 weeks (mm) 8.23 (1.12) 8.22 (1.12) 0.39 (-0.06, 0.84) 0.09
Weight at screening (kg) 0.81 (0.17) 0.70 (0.21) 0.09 (0.02, 0.15) 0.01
Weight at 36 weeks (kg) 1.99 (0.40) 1.84 (0.43) 0.15 (-0.008, 0.16) 0.06
Subarachnoid space (mm) 0.20 (0.05) 0.19 (0.07) 0.01 (-0.01, 0.03) 0.57
Thyroid volume 0.57 (0.18) 0.58 (0.16) -0.01 (-0.08, 0.06) 0.70
Mortality 14 (14%) 16 (28%) -0.18 (-0.34, -0.037) 0.01β
Duration of mechanical ventilation (days)
Median 19.0
IQR (13.38)
Median 22.0
IQR (14.42)
-6.0 (0.00, 13.0) 0.50#
Number with CLD 57 (58.8%) 24 (42.9%) 0.16 (-0.01, 0.32) 0.06β
Oxygen levels required at 36 weeks (L/min) for CLD Median 0.2
IQR (0.05, 1.5)
Median 0.5
IQR (0.08, 1.8)
0.00 (-0.23, 0.20) 0.86#
Data expressed as mean (SD) for continuous parametric outcomes, Student t-test; x (%) for categorical outcomes, βchi-square; median and IQR for non 
parametric outcomes; #Mann-Whitney U-Wilcoxon test.
SGA: small for gestational age, AGA: appropriate-for-gestational age, CLD: chronic lung disease, CRIB: Clinical Risk Index for Babies, CRP: C-reactive protein, 
IQR: interquartile ranges, SD: standard deviation
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